glp 1 receptor protein Glucagon-like peptide-1 Med14 essential for GLP-1 agonist

"The field is also exploring migraine, intracranial hypertension, inflammatory bowel disease, psoriasis, and rheumatoid arthritis, all out of my wheelhouse," he says

PMID: 23882053

On the flip side, use of GLP-1s could potentially decrease the risk of serious cardiac events like heart attack

This strategy holds promise for developing oral peptide therapeutics with enhanced bioavailability and therapeutic efficacy, exemplified by the success of biotinylated GLP-1 analogues in improving glucose control

What's often missing is comprehensive system evaluation gut integrity testing, body composition analysis, toxin assessment, muscle preservation strategy, lifestyle translation, and a long-term exit plan